⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REPL News
Replimune Group, Inc.
Replimune Group, Inc. (REPL) Investors Who Suffered Losses Are Encouraged to Contact Johnson Fistel Following FDA Briefing Document
globenewswire.com
REPL
Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Replimune Group, Inc. (REPL)
globenewswire.com
REPL
Form 8-K
sec.gov
REPL
Replimune Reports Fiscal Fourth Quarter and Year End 2026 Financial Results and Provides Corporate Update
globenewswire.com
REPL
Form 8-K
sec.gov
REPL
Replimune Announces FDA Acceptance of RP1 Biologics License Application Resubmission for Advanced Melanoma
globenewswire.com
REPL
AI Code Assistants Market Surges to $127.05 billion at a CAGR 48.1% by 2032 | Exclusive Report by MarketsandMarkets™
globenewswire.com
IBM
ORCL
MSFT
AMZN
GOOGL
REPL
DDOG
CRM
Replimune Presents Final First-in-Human Data for RP2 in Advanced Solid Tumors During Oral Presentation at the 2026 American Society of Clinical Oncology Annual Meeting
globenewswire.com
REPL
Replimune Presents 3-Year Landmark Overall Survival Analysis from IGNYTE Clinical Trial During Oral Presentation at the 2026 American Society of Clinical Oncology Annual Meeting
globenewswire.com
REPL
Form 8-K
sec.gov
REPL